tiprankstipranks
Trending News
More News >
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Germany Market

OSE Immunotherapeutics SA (6OP) Financial Statements

Compare
1 Followers

OSE Immunotherapeutics SA Financial Overview

OSE Immunotherapeutics SA's market cap is currently €114.40M. The company's EPS TTM is €-0.683; its P/E ratio is -3.26; OSE Immunotherapeutics SA is scheduled to report earnings on October 15, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 69.88M€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Gross Profit€ 69.88M€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Operating Income€ 43.73M€ -22.99M€ -18.48M€ -16.63M€ -18.99M
EBITDA€ 41.20M€ -17.50M€ -13.11M€ -13.72M€ -18.24M
Net Income€ 37.45M€ -23.00M€ -17.76M€ -16.85M€ -16.55M
Balance Sheet
Cash & Short-Term Investments€ 16.75M€ 18.67M€ 25.62M€ 33.58M€ 29.37M
Total Assets€ 123.96M€ 82.05M€ 91.67M€ 101.52M€ 96.85M
Total Debt€ 46.13M€ 45.80M€ 44.79M€ 37.13M€ 19.51M
Net Debt€ 29.39M€ 27.13M€ 19.17M€ 3.55M€ -9.85M
Total Liabilities€ 60.15M€ 59.08M€ 59.12M€ 53.99M€ 35.61M
Stockholders' Equity€ 63.81M€ 22.82M€ 32.55M€ 47.89M€ 61.24M
Cash Flow
Free Cash Flow€ 48.36M€ -20.00M€ -18.53M€ -10.39M€ -19.76M
Operating Cash Flow€ 48.44M€ -19.76M€ -18.25M€ -9.92M€ -19.55M
Investing Cash Flow€ -46.91M€ -507.00K€ 26.00K€ -827.00K€ -504.00K
Financing Cash Flow€ -3.46M€ 13.32M€ 10.27M€ 14.96M€ 23.58M
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History

OSE Immunotherapeutics SA Debt to Assets

OSE Immunotherapeutics SA Cash Flow

OSE Immunotherapeutics SA Forecast EPS vs Actual EPS